| Dr Michael B Marchildon, MD | |
|
Virtua And Dupont Childrens Health Program, 1000 White Horse Road Suite 204, Voorhees, NJ 08043-4406 | |
| (856) 309-8508 | |
| (856) 309-8556 |
| Full Name | Dr Michael B Marchildon |
|---|---|
| Gender | Male |
| Speciality | Surgery - Pediatric Surgery |
| Location | Virtua And Dupont Childrens Health Program, Voorhees, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447340179 | NPI | - | NPPES |
| 3716708 | Medicaid | NJ | |
| 4881036 | Medicaid | MD | |
| 1176902 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0120X | Surgery - Pediatric Surgery | MA03903300 (New Jersey) | Primary |
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20081202000185 |
News Archive
Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.
Nearly one million people in the UK are living with heart failure, and this is set to rise by 50% over the next couple of decades.
The corona crisis appears to have had a negative impact on the mental health of the Danish population, but research from Aarhus University shows that the psychological well-being had improved already by the end of April.
About three-quarters of cases of central precocious puberty in boys have no identifiable cause, say researchers.
› Verified 1 days ago
| Entity Name | New York University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285826438 PECOS PAC ID: 1355232422 Enrollment ID: O20090822000026 |
News Archive
Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.
Nearly one million people in the UK are living with heart failure, and this is set to rise by 50% over the next couple of decades.
The corona crisis appears to have had a negative impact on the mental health of the Danish population, but research from Aarhus University shows that the psychological well-being had improved already by the end of April.
About three-quarters of cases of central precocious puberty in boys have no identifiable cause, say researchers.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michael B Marchildon, MD Po Box 191, Provider Enrollment Dept, Rockland, DE 19732-0191 Ph: (302) 651-6212 | Dr Michael B Marchildon, MD Virtua And Dupont Childrens Health Program, 1000 White Horse Road Suite 204, Voorhees, NJ 08043-4406 Ph: (856) 309-8508 |
News Archive
Sanofi and its subsidiary Genzyme announced today that the U.S. Food and Drug Administration has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Lemtrada should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.
Nearly one million people in the UK are living with heart failure, and this is set to rise by 50% over the next couple of decades.
The corona crisis appears to have had a negative impact on the mental health of the Danish population, but research from Aarhus University shows that the psychological well-being had improved already by the end of April.
About three-quarters of cases of central precocious puberty in boys have no identifiable cause, say researchers.
› Verified 1 days ago
Charles Butler, M.D. Surgery Medicare: Medicare Enrolled Practice Location: 502 Centennial Blvd, Suite 7, Voorhees, NJ 08043 Phone: 856-596-7440 Fax: 856-596-6723 | |
Nicole Melchior, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Bowman Dr Ste E300, Voorhees, NJ 08043 Phone: 856-247-7515 | |
Aziz Sadiq, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Bowman Dr Ste E355, Voorhees, NJ 08043 Phone: 856-247-7210 Fax: 856-247-7511 | |
Blair Hermansky, CORT Surgery Medicare: Not Enrolled in Medicare Practice Location: 1307 White Horse Rd Ste C501, Voorhees, NJ 08043 Phone: 856-784-2659 | |
Robert Minor, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 130 Carnie Blvd, Suite 4, Voorhees, NJ 08043 Phone: 856-596-7440 Fax: 856-751-3320 | |
Alexandra Chudner, Surgery Medicare: Accepting Medicare Assignments Practice Location: 200 Bowman Dr Ste E355, Voorhees, NJ 08043 Phone: 856-247-7210 Fax: 856-247-7511 | |
Edwin Empaynado, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 502 Centennial Blvd, Suite 5, Voorhees, NJ 08043 Phone: 856-429-8030 Fax: 856-428-2718 |